Home
Conditions
Neoplasms, Ductal, Lobular, and Medullary

Clinical trial condition

Neoplasms, Ductal, Lobular, and Medullary

Explore clinical trials studying Neoplasms, Ductal, Lobular, and Medullary. Study availability and eligibility vary by location and protocol.

487 public trials 100 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Ductal, Lobular, and Medullary trial results

Recruiting

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07259317

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +12 more
Locations: Site 02 Scottsdale, Arizona, United States

Site 04 Los Angeles, California, United States

Site 12 Orange, California, United States

Site 06 Atlanta, Georgia, United States

View all 20 locations

View Trial Details

Recruiting

Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management

NCT04216732

Conditions: Adenocarcinoma, Advanced Thyroid Gland Medullary Carcinoma, Carcinoma, +15 more
Locations: University of California San Francisco San Francisco, California, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

NCT07142005

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +11 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

CAN1012 in Pre-Malignant DCIS and LCIS

NCT07408856

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +13 more
Locations: Providence Portland Cancer Institute - Franz Clinic Portland, Oregon, United States

View Trial Details

Recruiting

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

NCT07214532

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

Honor Health Research Institute Scottsdale, Arizona, United States

University of Arizona Cancer Center Tucson, Arizona, United States

Marin Cancer Care Greenbrae, California, United States

View all 49 locations

View Trial Details

Recruiting

Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy

NCT07711847

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +8 more
Locations: NYU Grossman School of Medicine New York, United States

View Trial Details

Recruiting

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

NCT06814496

Conditions: Adenocarcinoma, Astrocytoma, Bladder Cancer, +74 more
Locations: Arizona Cancer Center at UMC North/University Medical Center Tucson, Arizona, United States

University of Washington Fred Hutchinson Cancer Center Seattle, Washington, United States

Banner MD Anderson Cancer Center Gilbert, Arizona, United States

View Trial Details

Recruiting

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

NCT07006727

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations: University Of Iowa Iowa City, Iowa, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Corewell Health William Beaum Hosp Royal Oak, Michigan, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Recruiting

UCSF PANC Cyst Registry

NCT04291651

Conditions: Adenoma, Cystadenoma, Cystadenoma, Serous, +21 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Recruiting

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

NCT06445062

Conditions: Adenocarcinoma, CRC, Carcinoma, +25 more
Locations: Ironwood Cancer and Research Centers Chandler, Arizona, United States

Mayo Clinic Hospital Phoenix, Arizona, United States

HonorHealth Research Institute Scottsdale, Arizona, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

View all 32 locations

View Trial Details

Neoplasms, Ductal, Lobular, and Medullary

Neoplasms, Ductal, Lobular, and Medullary trial results

Related conditions